Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Goodwill (2016 - 2023)

Historic Goodwill for Angiodynamics (ANGO) over the last 15 years, with Q4 2023 value amounting to $159.2 million.

  • Angiodynamics' Goodwill fell 2068.64% to $159.2 million in Q4 2023 from the same period last year, while for Nov 2023 it was $159.2 million, marking a year-over-year decrease of 2068.64%. This contributed to the annual value of $159.2 million for FY2023, which is 2080.0% down from last year.
  • According to the latest figures from Q4 2023, Angiodynamics' Goodwill is $159.2 million, which was down 2068.64% from $159.0 million recorded in Q3 2023.
  • Over the past 5 years, Angiodynamics' Goodwill peaked at $423.7 million during Q1 2019, and registered a low of $12.4 million during Q4 2019.
  • In the last 5 years, Angiodynamics' Goodwill had a median value of $201.1 million in 2021 and averaged $219.0 million.
  • In the last 5 years, Angiodynamics' Goodwill plummeted by 7409.86% in 2019 and then skyrocketed by 151825.72% in 2020.
  • Quarter analysis of 5 years shows Angiodynamics' Goodwill stood at $12.4 million in 2019, then soared by 1518.26% to $201.1 million in 2020, then increased by 0.29% to $201.7 million in 2021, then decreased by 0.47% to $200.8 million in 2022, then dropped by 20.69% to $159.2 million in 2023.
  • Its Goodwill stands at $159.2 million for Q4 2023, versus $159.0 million for Q3 2023 and $159.2 million for Q2 2023.